School of Medicine


Showing 11-20 of 63 Results

  • Matt van de Rijn

    Matt van de Rijn

    Sabine Kohler, MD, Professor of Pathology

    Current Research and Scholarly InterestsOur research focuses on molecular analysis of human soft tissue tumors (sarcomas) with an emphasis on leiomyosarcoma and desmoid tumors. In addition we study the role of macrophages in range of malignant tumors.

  • Pieter van der Starre

    Pieter van der Starre

    Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsCardiovascular Pharmacology, Cardiovascular Physiology,
    Neurophysiology and Monitoring,
    Transesophageal Echocardiography

  • Keith Van Haren, MD

    Keith Van Haren, MD

    Assistant Professor of Neurology and of Pediatrics

    Current Research and Scholarly InterestsOur research group is dedicated to innovating care for children with degenerative brain disorders. We are particularly focused on genetic and autoimmune disorders that cause damage to the myelin (the fatty insulation around the nerves) of the brain and spinal cord. X-linked adrenoleukodystrophy (genetic) and multiple sclerosis (autoimmune) are the prototypical examples of degenerative disorders of myelin and are the two disorders we study most intensively.

  • Krisa Van Meurs

    Krisa Van Meurs

    Rosemarie Hess Professor, Emerita

    Current Research and Scholarly InterestsMy research interests include persistent pulmonary hypertension of the newborn, hypoxic respiratory failure, inhaled nitric oxide therapy, ECMO, congenital diaphragmatic hernia, neonatal clinical trials, and the use of aEEG and NIRS to detect brain injury.

  • Capucine van Rechem

    Capucine van Rechem

    Assistant Professor of Pathology (Pathology Research)

    Current Research and Scholarly InterestsMy long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved. My laboratory explores the direct molecular impact of chromatin-modifying enzymes during cell cycle progression, and characterizes the unappreciated and unconventional roles that these chromatin factors have on cytoplasmic function such as protein synthesis.

  • Peter Johannes van Roessel

    Peter Johannes van Roessel

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioDr. Peter van Roessel, MD PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City. He has pursued additional training in psychodynamic psychotherapy (TFP) via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University, where he provided clinical care for individuals participating in research studies across a spectrum of psychiatric illness, including treatment resistant mood disorders, anxiety disorders, psychosis and substance use disorders.

    At Stanford, he sees adult mood and anxiety disorders outpatients through the Assessment Clinics and participates in resident training and patient care as a supervisor in psychodynamic psychotherapy and psychopharmacology. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and contributes to and directs clinical neuroscience studies pioneering rapid-acting interventions in OCD.

    Dr. van Roessel pursued research training basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. More recently, he has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. In the Rodriguez Lab, he is pursuing clinically-motivated research interests related to the nature and neural correlates of insight in obsessive-compulsive and related disorders. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he is a 2020-2021 Miller Foundation Fellow, and is a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA.